Showing results (91-100 of 114) with videos related to

Sort By:
Pageof 12
International Journal of Oncology|April 2, 2011
VEGF-A not Ang2 mediates endothelial-like differentiation of immature DCs by ERK1/2 signaling in the microenvironment of human colon adenocarcinomaJing Lu, Kangdong Liu, Jimin Zhao, et al.
International Immunopharmacology|June 12, 2025
JAK3/STAT5A-dependent IL-8 regulation drives ESCC angiogenesis and is suppressed by dihydroartemisininKai Zhang, Xiaoshuo Dai, Wei Chen, et al.
Oncology Reports|January 1, 2016
A method for establishing a patient-derived xenograft model to explore new therapeutic strategies for esophageal squamous cell carcinomaYanan Jiang, Qiong Wu, Xiawen Yang, et al.
Neoplasia (New York, N.Y.)|June 18, 2021
DNA polymerase β deficiency promotes the occurrence of esophageal precancerous lesions in miceJiace Qin, Yanyan Zhu, Yongwei Ding, et al.
Oncogene|September 17, 2024
DDX5 promotes esophageal squamous cell carcinoma growth through sustaining VAV3 mRNA stabilityYunshu Shi, Junyong Wang, Qiang Yuan, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|March 14, 2026
Diosmetin alleviates the immunosuppressive tumor microenvironment in esophageal squamous cell carcinoma by dually inhibiting angiogenesis and promoting CD8+T cell cytotoxicityXiaoxuan Duan, Xiaoshuo Dai, Xiaoya Li, et al.
Molecular Carcinogenesis|December 8, 2020
p21-activated kinase 4 promotes the progression of esophageal squamous cell carcinoma by targeting LASP1Hui Huang, Qianqian Xue, Xiaoge Du, et al.
Frontiers in Pharmacology|March 4, 2021
Dihydroartemisinin Inhibits the Proliferation of Esophageal Squamous Cell Carcinoma Partially by Targeting AKT1 and p70S6KLili Zhu, Xinhuan Chen, Yanyan Zhu, et al.
Molecular Carcinogenesis|April 13, 2025
SRPK1 Activation Facilitates Gli3S664 Phosphorylation and Promotes Metastasis in Esophageal Squamous Cell CarcinomaYongwei Ding, Jiace Qin, Mengjia Zhang, et al.
Molecular Pharmaceutics|October 31, 2025
Fc-Engineered B7-H3 Antibody with Prolonged Serum Half-Life for Enhanced Cancer TherapyHuiting Wu, Mengjia Zhang, Tingting Wang, et al.
Pageof 12